Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon bought 24 shares of the firm’s stock in a transaction that occurred on Wednesday, April 17th. The stock was purchased at an average cost of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92).
Johnson Matthey Stock Performance
Shares of JMAT stock opened at GBX 1,753 ($21.82) on Friday. Johnson Matthey PLC has a 12 month low of GBX 1,428.50 ($17.78) and a 12 month high of GBX 1,986.31 ($24.73). The stock has a market cap of £3.22 billion, a PE ratio of 1,826.04, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.98. The company has a current ratio of 1.51, a quick ratio of 0.76 and a debt-to-equity ratio of 63.95. The company’s fifty day moving average price is GBX 1,702.30 and its 200-day moving average price is GBX 1,625.82.
Analyst Upgrades and Downgrades
Several brokerages recently commented on JMAT. Numis Securities reaffirmed a “buy” rating and issued a GBX 2,200 ($27.39) target price on shares of Johnson Matthey in a research note on Wednesday, March 20th. Berenberg Bank lifted their target price on shares of Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research note on Monday, April 8th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,100 ($26.14) target price on shares of Johnson Matthey in a research note on Wednesday, March 20th. One research analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 2,010 ($25.02).
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Comprehensive PepsiCo Stock Analysis
- What is a Bond Market Holiday? How to Invest and Trade
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Bear Market Funds to Watch This Year
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.